Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionRockefeller Capital Management L.P.
Latest Disclosed Ownership104,165 shares
Latest Disclosed Value $ 14,517,531
Rockefeller Capital Management L.P. reports 17.18% increase in ownership of GILD / Gilead Sciences, Inc.

On May 14, 2026 - Rockefeller Capital Management L.P. filed a 13F-HR form disclosing ownership of 104,165 shares of Gilead Sciences, Inc. (CH:GILD) valued at $14,517,531 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 16, 2026 disclosing 88,893 shares of Gilead Sciences, Inc.. This represents a change in shares of 17.18% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GILEAD SCIENCES COM 375558103 104,165 15,272 17.18 14,518 33.06 0.0133
2026-03-16 2025-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 88,893 22,559 34.01 10,911 48.17 0.0196
2026-02-14 2025-12-31 13F GILEAD SCIENCES COM 375558103 88,917 22,583 10,916 0.0100
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 66,334 -4,226 -5.99 7,363 -5.88 0.0144
2025-08-14 2025-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 70,560 -13,803 -16.36 7,823 -17.23 0.0172
2025-08-08 2025-06-30 13F GILEAD SCIENCES COM 375558103 70,560 -13,803 7,823 0.0099
2025-05-14 2025-03-31 13F GILEAD SCIENCES COM 375558103 84,363 7,916 10.35 9,453 33.99 0.0233
2025-02-13 2024-12-31 13F GILEAD SCIENCES COM 375558103 76,447 1,348 1.79 7,055 12.11 0.0183
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 75,099 -1,402 -1.83 6,293 19.85 0.0169
2024-08-12 2024-06-30 13F GILEAD SCIENCES COM 375558103 76,501 -21,165 -21.67 5,250 -26.61 0.0149
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM 375558103 97,666 1,589 1.65 7,154 -8.08 0.0209
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 96,077 -16,763 -14.86 7,783 -7.96 0.0260
2023-11-14 2023-09-30 13F GILEAD SCIENCES COM 375558103 112,840 12,871 12.87 8,456 9.76 0.0326
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 99,969 1,221 1.24 7,705 96,200.00 0.0298
2023-05-16 2023-03-31 13F GILEAD SCIENCES COM 375558103 98,748 -28,489 -22.39 8 -99.93 0.0352
2023-03-06 2022-12-31 13F GILEAD SCIENCES COM 375558103 127,237 -70,345 -35.60 10,922 -10.39 0.0549
2022-11-02 2022-09-30 13F GILEAD SCIENCES COM 375558103 197,582 40,229 25.57 12,188 25.33 0.0630
2022-08-12 2022-06-30 13F GILEAD SCIENCES COM 375558103 157,353 6,063 4.01 9,725 8.14 0.0517
2022-05-13 2022-03-31 13F GILEAD SCIENCES COM 375558103 151,290 8,587 6.02 8,993 -13.20 0.0434
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 142,703 4,480 3.24 10,361 7.32 0.0484
2021-11-12 2021-09-30 13F GILEAD SCIENCES COM 375558103 138,223 28,235 25.67 9,654 27.48 0.0507
2021-08-10 2021-06-30 13F GILEAD SCIENCES COM 375558103 109,988 66,789 154.61 7,573 171.34 0.0427
2021-05-11 2021-03-31 13F GILEAD SCIENCES COM 375558103 43,199 6,253 16.92 2,791 29.75 0.0189
2021-02-12 2020-12-31 13F GILEAD SCIENCES COM 375558103 36,946 1,123 3.13 2,151 -4.95 0.0163
2020-11-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 35,823 10,854 43.47 2,263 17.80 0.0212
2020-08-12 2020-06-30 13F GILEAD SCIENCES COM 375558103 24,969 1,183 4.97 1,921 8.04 0.0201
2020-05-12 2020-03-31 13F GILEAD SCIENCES COM 375558103 23,786 1,296 5.76 1,778 21.70 0.0233
2020-02-07 2019-12-31 13F GILEAD SCIENCES COM 375558103 22,490 10,915 94.30 1,461 99.32 0.0182
2019-11-12 2019-09-30 13F GILEAD SCIENCES COM 375558103 11,575 -22,373 -65.90 733 -68.05 0.0099
2019-08-09 2019-06-30 13F GILEAD SCIENCES COM 375558103 33,948 -1,894 -5.28 2,294 -1.55 0.0320
2019-05-10 2019-03-31 13F GILEAD SCIENCES COM 375558103 35,842 -16,123 -31.03 2,330 -28.31 0.0332
2019-02-12 2018-12-31 13F GILEAD SCIENCES COM 375558103 51,965 42,385 442.43 3,250 339.19 0.0570
2018-11-02 2018-09-30 13F Gilead Sciences Common 375558103 9,580 -10,381 -52.01 740 -47.67 0.0112
2018-07-31 2018-06-30 13F Gilead Sciences Common 375558103 19,961 2,147 12.05 1,414 5.29 0.0230
2018-05-09 2018-03-31 13F Gilead Sciences Common 375558103 17,814 17,814 1,343 0.0222
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.